NHS England chief executive Simon Stevens said the regulator is making contingency plans for possible supply disruptions as part of the UK's exit from the EU, The Guardian reported Sunday.
The Association of the British Pharmaceutical Industry has warned that patients could face hardships if the UK fails to secure an agreement for the import of drugs and medical equipment with the EU.
"There's been significant planning going on around the scenarios...nobody is in any doubt whatsoever that...in terms of ensuring continued supplies for all the thing that we need in this country, at the top of the list has got to be those medical supplies," commented Stevens.
"There's extensive work under way now between the Department of Health, other parts of government, the life sciences industry, the pharma companies, so nobody's pretending this is a desirable situation but if that’s where we get to then it will not have been unforeseen," Stevens added.
The news comes after the British Medical Association described Brexit as "bad for Britain's health" and endorsed a second public referendum on the issue.
In response to concerns about a "brain drain" following Brexit, Stevens detailed the registration process for EU citizens who wish to remain in the UK but stressed the need for additional home-grown talent.
To read more NewsPoints articles, click here.